Neuraltus ALS drug wins fast track, orphan status - San Francisco Business Times**** "An experimental treatment for Lou Gehrig’s disease won fast track and orphan drug designations from the Food and Drug Administration, potentially speeding ..."·bizjournals.com·Aug 27, 2021Neuraltus ALS drug wins fast track, orphan status - San Francisco Business Times
